ALKERMES | Продажи

Sales Изменить Дата
AbbVie USD 12.31B 1.99B 2024-03
Acadia Pharmaceuticals USD 205.8M 25.24M 2024-03
ALKERMES USD 350.4M 27.08M 2024-03
Amgen USD 7.45B 746M 2024-03
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
Intra Cellular Therapies USD 144.84M 12.74M 2024-03
Ionis Pharmaceuticals USD 119M 206M 2024-03
J&J USD 21.38B 15M 2024-03
Malin Corporation EUR 19.2M 2.6M 2020-12
Merck USD 15.8B 1.17B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Otsuka Holdings JPY 519.52B 19.97B 2024-03
Pfizer USD 14.9B 651M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Vertex Pharmaceuticals USD 2.69B 172.3M 2024-03



ALKERMES Продажи - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2024.